Similar articles

• [Duchenne muscular dystrophy. Effects of vitamin E administration on urinary luminescence].

  Pizarro M, Lissi E, Reyes J, Holmgren J. Pizarro M, et al. Rev Med Chil. 1998 Oct;126(10):1165-72. Rev Med Chil. 1998. PMID: 10030087 Spanish.
• [Glucocorticoid therapy in Duchenne muscular dystrophy].

  Kang J. Kang J. Rinsho Shinkeigaku. 1996 Dec;36(12):1338-40. Rinsho Shinkeigaku. 1996. PMID: 9128400 Clinical Trial. Japanese.
• Suggestion for a possible mitigating treatment of Duchenne muscular dystrophy.

  Zatz M, Frota-Pessoa O. Zatz M, et al. Am J Med Genet. 1981;10(3):305-7. doi: 10.1002/ajmg.1320100314. Am J Med Genet. 1981. PMID: 7304675 No abstract available.
• [Duchenne muscular dystrophy: clinical analysis and prospects of genetic therapy].

  Mateos F. Mateos F. Rev Neurol. 1995;23 Suppl 3:S404-7. Rev Neurol. 1995. PMID: 7497322 Review. Spanish. No abstract available.
• [Therapeutic strategy for muscular dystrophies].

  Shin JH, Takeda S. Shin JH, et al. Brain Nerve. 2007 Apr;59(4):415-24. Brain Nerve. 2007. PMID: 17447528 Review. Japanese.